(September 14, 2021, 2:00 PM EDT) -- MIAMI — An investor sued a clinical-stage biopharmaceutical company and certain of its senior executives in Florida federal court on Sept. 13, alleging that the defendants violated federal securities laws by failing to disclose disappointing Phase 2b clinical trial results for the company’s aging-related condition treatment drug candidate....